IE
SGYP

Israel Englander’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Israel Englander’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,000
Closed -$609K – 4032
2016
Q4 		$609K Hold
100,000
– – ﹤0.01% 2572
2016
Q3 		$551K Buy
+100,000
New +$468K ﹤0.01% 2556
2015
Q3 		– Sell
-200,000
Closed -$1.66M – 3889
2015
Q2 		$1.66M Hold
200,000
– – ﹤0.01% 2024
2015
Q1 		$924K Buy
+200,000
New +$650K ﹤0.01% 2358

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Israel Englander's SGYP Position: Q4 2018 in Review

Israel Englander sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 12,504 shares — an estimated $21K sold.

Israel Englander first reported a position in SGYP in Q2 2013 and held it in 21 quarters. The position peaked at $19.2M in Q2 2015. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Israel Englander reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Israel Englander sold 12,504 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $21K.
  • Israel Englander first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 21 quarters.
  • Israel Englander's Synergy Pharmaceuticals, Inc Common Stock position peaked at $19.2M in Q2 2015.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.